A glioneuronal tumor with neurocytic rosettes harboring FGFR1 internal tandem duplication - A report of a unique case

. 2025 Jun ; 45 (3) : 234-240. [epub] 20241125

Jazyk angličtina Země Austrálie Médium print-electronic

Typ dokumentu kazuistiky, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid39586795

Grantová podpora
BBMRI-CZ
Univerzita Karlova v Praze
Ministerstvo Obrany České Republiky

Rosette-forming glioneuronal tumors (RGNTs) with FGFR1 tyrosine kinase domain internal tandem duplication (FGFR1 ITD) is exceedingly rare, with only a few cases reported in the literature. Hereby we present a case of a tumor with RGNT morphology occurring in area of septum pellucidum of 43-year-old male. The tumor showed FGFR1 ITD, no PIK3CA, PIK3R1 or NF1 alterations and inconclusive methylation profile with match for class of "low-grade glial/glioneuronal/neuroepithelial tumors". No areas characteristic of dysembryoplastic neuroepithelial tumor were identified. A brief review of literature on discrepancies between morphological diagnosis of RGNT and molecular profile of the entity is provided.

Zobrazit více v PubMed

Appay R, Bielle F, Sievers P et al. Rosette‐forming glioneuronal tumours are midline, FGFR1‐mutated tumours. Neuropathol Appl Neurobiol 2022; 48: e12813.

Sievers P, Appay R, Schrimpf D et al. Rosette‐forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co‐mutation of PIK3CA and NF1. Acta Neuropathol 2019; 138: 497–504.

Komori T, Scheithauer BW, Hirose T. A rosette‐forming glioneuronal tumor of the fourth ventricle: Infratentorial form of dysembryoplastic neuroepithelial tumor? Am J Surg Pathol 2002; 26: 582–591.

Lucas CG, Gupta R, Doo P et al. Comprehensive analysis of diverse low‐grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette‐forming glioneuronal tumor. Acta Neuropathol Commun 2020; 8: 151.

Rivera B, Gayden T, Carrot‐Zhang J et al. Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors. Acta Neuropathol 2016; 131: 847–863.

Ryall S, Zapotocky M, Fukuoka K et al. Integrated molecular and clinical analysis of 1,000 pediatric low‐grade gliomas. Cancer Cell 2020; 37: 569–583.

Matsumura N, Nobusawa S, Ito J et al. Multiplex ligation‐dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumors. J Neuro‐Oncol 2019; 143: 27–33.

Bale TA. FGFR‐ gene family alterations in low‐grade neuroepithelial tumors. Acta Neuropathol Commun 2020; 8: 21.

Lucas CG, Villanueva‐Meyer JE, Whipple N et al. Myxoid glioneuronal tumor, PDGFRA p.K385‐mutant: Clinical, radiologic, and histopathologic features. Brain Pathol 2020; 30: 479–494.

Thom M, Toma A, An S et al. One hundred and one dysembryoplastic neuroepithelial tumors: An adult epilepsy series with immunohistochemical, molecular genetic, and clinical correlations and a review of the literature. J Neuropathol Exp Neurol 2011; 70: 859–878.

Chen SY, Wang W, Wang LM et al. Glioneuronal tumours with features of rosette‐forming glioneuronal tumours of the fourth ventricle and dysembryoplastic neuroepithelial tumours: A report of three cases. Histopathology 2016; 68: 378–387.

Matyja E, Grajkowska W, Kunert P, Marchel A. A peculiar histopathological form of dysembryoplastic neuroepithelial tumor with separated pilocytic astrocytoma and rosette‐forming glioneuronal tumor components. Neuropathology 2014; 34: 491–498.

Sumitomo N, Ishiyama A, Shibuya M et al. Intractable epilepsy due to a rosette‐forming glioneuronal tumor with a dysembryoplastic neuroepithelial background. Neuropathology 2018; 38: 300–304.

Uchiyama T, Gomi A, Nobusawa S, Fukushima N, Matsubara D, Kawai K. A case of a rosette‐forming glioneuronal tumor with clinicopathological features of a dysembryoplastic neuroepithelial tumor and fibroblast growth factor receptor 1 internal tandem duplication. Brain Tumor Pathol 2021; 38: 250–256.

Louis DN, Wesseling P, Paulus W et al. cIMPACT‐NOW update 1: Not otherwise specified (NOS) and not elsewhere classified (NEC). Acta Neuropathol 2018; 135: 481–484.

Halfpenny A, Ferris SP, Grafe M et al. A case of recurrent epilepsy‐associated rosette‐forming glioneuronal tumor with anaplastic transformation in the absence of therapy. Neuropathology 2019; 39: 389–393.

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...